General Mills Inc issued a voluntary recall of about 10 million pounds of flour, saying it was working with health officials to investigate an outbreak of E. coli that had sickened 38 people in 20 U.S. states.
U.S. FDA Approves Once-daily Jentadueto XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes
The U.S. Food and Drug Administration has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes (T2D) in adults.
The U.S. Supreme Court rejected Cubist Pharmaceuticals Inc’s bid to revive four patents for its antibiotic drug Cubicin, paving the way for rival Hospira Inc to introduce a generic version as soon as this year.
Daiichi Sankyo Co Ltd said it will not proceed with the second part of its late-stage study on the lung cancer drug, patritumab.
Amicus Therapeutics Inc said the European Commission approved the use of migalastat, its experimental treatment for Fabry disease, an inherited disease that creates pain and burning in the hands and feet.
Israel-based Teva Pharmaceutical Industries said on Tuesday approval for a drug to treat chorea stemming from Huntington disease has been held up by U.S. regulators seeking further blood study.
FDA granted accelerated approval to Ocaliva, the first new medicine for primary biliary cholangitis in nearly 20 years.
A once-per-month injection for MS developed by Biogen and AbbVie received FDA approval.
Jazz Pharmaceuticals struck a deal to acquire Celator Pharmaceuticals and its promising leukemia drug for $1.5 billion.
Drugmaker Roche has received European approval for an injectable form of antibody therapy MabThera for people with chronic lymphocytic leukemia.